Tremeau Pharmaceuticals

Tremeau Pharmaceuticals is a private clinical-stage company located in Massachusetts, dedicated to commercializing non-opioid pain therapies targeting severe rare diseases influenced by the cyclooxygenase (COX) or prostaglandin pathway. They focus exclusively on orphan or unique conditions with unmet medical needs.